Jessica L Chan1,2, Joseph Letourneau3, Wael Salem3,4, Aylin Pelin Cil3,5, Sai-Wing Chan3, Lee-May Chen3, Mitchell P Rosen3. 1. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco School of Medicine, 499 Illinois Street, Sixth Floor, San Francisco, CA, 94158, USA. jessicachanmd@gmail.com. 2. Department of Obstetrics and Gynecology, University of Pennsylvania, 3701 Market Street, Suite 800, Philadelphia, PA, 19104, USA. jessicachanmd@gmail.com. 3. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco School of Medicine, 499 Illinois Street, Sixth Floor, San Francisco, CA, 94158, USA. 4. Department of Obstetrics and Gynecology, University of Southern California, 1240 North Mission Road, Los Angeles, CA, 90033, USA. 5. Istanbul Memorial Hospital ART and Reproductive Genetics Center, Piyale Pasa Bulvari, 34385, Okmeydani Sisli, Istanbul, Turkey.
Abstract
PURPOSE: Data have demonstrated an association between regret and lack of fertility counseling among patients undergoing treatment for non-gynecologic cancers. We sought to determine if fertility-related regret is reduced with pre-treatment counseling or fertility-sparing surgery (FSS) in patients with gynecologic cancers. METHODS: A cross-sectional survey was administered to 593 reproductive-age survivors (18-40 years old at diagnosis) of localized cervix, ovarian, or endometrial cancers that were eligible for FSS. A validated decision regret score was used to evaluate regret in patients. RESULTS: Four hundred seventy women completed the survey. Forty-six percent received pre-treatment counseling about treatment's effects on fertility. Having received counseling (adjusted ß-coefficient of -1.24, 95 % CI = -2.29 to -0.18, p = 0.02), satisfactory counseling (adjusted ß-coefficient of -2.71, 95 % CI = -3.86 to -1.57, p < 0.001), and FSS (adjusted ß-coefficient of -1.26, 95 % CI = -2.39 to -0.14, p = 0.03) were associated with lower regret post-treatment, after adjusting for age. Time since diagnosis, prior parity, socioeconomic status and cancer type were not associated with regret (p > 0.05). While 50 % of women reported desiring more children after diagnosis, desire for children after treatment was associated with increased regret (adjusted ß-coefficient of 3.97, 95 % CI = 2.92-5.02, p < 0.001). CONCLUSIONS: Though less than half of study participants received counseling about the effect of cancer treatment on future fertility, both fertility counseling and FSS were associated with decreased regret in reproductive-aged women with gynecologic cancers. The desire for more children after treatment was associated with increased regret. IMPLICATIONS FOR CANCER SURVIVORS: Inquiring about fertility desires and providing counseling regarding reproductive outcomes following cancer treatment should be implemented as part of the treatment process.
PURPOSE: Data have demonstrated an association between regret and lack of fertility counseling among patients undergoing treatment for non-gynecologic cancers. We sought to determine if fertility-related regret is reduced with pre-treatment counseling or fertility-sparing surgery (FSS) in patients with gynecologic cancers. METHODS: A cross-sectional survey was administered to 593 reproductive-age survivors (18-40 years old at diagnosis) of localized cervix, ovarian, or endometrial cancers that were eligible for FSS. A validated decision regret score was used to evaluate regret in patients. RESULTS: Four hundred seventy women completed the survey. Forty-six percent received pre-treatment counseling about treatment's effects on fertility. Having received counseling (adjusted ß-coefficient of -1.24, 95 % CI = -2.29 to -0.18, p = 0.02), satisfactory counseling (adjusted ß-coefficient of -2.71, 95 % CI = -3.86 to -1.57, p < 0.001), and FSS (adjusted ß-coefficient of -1.26, 95 % CI = -2.39 to -0.14, p = 0.03) were associated with lower regret post-treatment, after adjusting for age. Time since diagnosis, prior parity, socioeconomic status and cancer type were not associated with regret (p > 0.05). While 50 % of women reported desiring more children after diagnosis, desire for children after treatment was associated with increased regret (adjusted ß-coefficient of 3.97, 95 % CI = 2.92-5.02, p < 0.001). CONCLUSIONS: Though less than half of study participants received counseling about the effect of cancer treatment on future fertility, both fertility counseling and FSS were associated with decreased regret in reproductive-aged women with gynecologic cancers. The desire for more children after treatment was associated with increased regret. IMPLICATIONS FOR CANCER SURVIVORS: Inquiring about fertility desires and providing counseling regarding reproductive outcomes following cancer treatment should be implemented as part of the treatment process.
Authors: Shemille A Collingwood; Russell B McBride; Michael Leapman; Adele R Hobbs; Young Suk Kwon; Kristian D Stensland; Rebecca M Schwartz; Matthew E Pollard; David B Samadi Journal: Urol Oncol Date: 2014-01-09 Impact factor: 3.498
Authors: Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay Journal: J Clin Oncol Date: 2013-05-28 Impact factor: 44.544
Authors: Jamie C Brehaut; Annette M O'Connor; Timothy J Wood; Thomas F Hack; Laura Siminoff; Elisa Gordon; Deb Feldman-Stewart Journal: Med Decis Making Date: 2003 Jul-Aug Impact factor: 2.583
Authors: Neeraj K Arora; Ann S Hamilton; Arnold L Potosky; Julia H Rowland; Noreen M Aziz; Keith M Bellizzi; Carrie N Klabunde; Wendy McLaughlin; Jennifer Stevens Journal: J Cancer Surviv Date: 2007-03 Impact factor: 4.442
Authors: M Peate; B Meiser; B C Cheah; C Saunders; P Butow; B Thewes; R Hart; K-A Phillips; M Hickey; M Friedlander Journal: Br J Cancer Date: 2012-03-13 Impact factor: 7.640
Authors: Alexandra Higgins; Zaraq Khan; Charles C Coddington; Shahrukh K Hashmi; Mehrdad Hefazi; Hassan Alkhateeb; Mark R Litzow; William J Hogan; Elizabeth Cathcart-Rake; Carrie A Thompson; Mrinal M Patnaik Journal: Biol Blood Marrow Transplant Date: 2019-02-15 Impact factor: 5.742
Authors: Andrea C Johnson; Darren Mays; Kathryn Rehberg; Aziza Shad; Kenneth P Tercyak Journal: J Adolesc Young Adult Oncol Date: 2018-04-19 Impact factor: 2.223
Authors: Leah Hawkins Bressler; Jennifer E Mersereau; Chelsea Anderson; Juan L Rodriguez; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler; Hazel B Nichols Journal: Cancer Date: 2019-04-23 Impact factor: 6.860
Authors: J Alejandro Rauh-Hain; Jose Zubizarreta; Roni Nitecki; Alexander Melamed; Shuangshuang Fu; Kirsten Jorgensen; Paula C Brady; Valerie L Baker; Mariana Chavez-MacGregor; Sharon H Giordano; Nancy L Keating Journal: Cancer Date: 2022-06-29 Impact factor: 6.921